BRIEF published on 11/06/2025 at 13:05, 2 months 25 days ago Moderna annonce un chiffre d'affaires d'un milliard de dollars au troisième trimestre 2025, malgré des prévisions financières revues à la baisse pour 2025. Résultats Financiers Moderna Baisse Des Revenus Vaccin Contre Le Covid-19 Efficacité En Matière De Coûts
PRESS RELEASE published on 11/06/2025 at 13:00, 2 months 25 days ago Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates Moderna, Inc. reports Q3 revenue of $1.0B with a net loss of $(0.2)B. Narrows 2025 revenue range and improves operating expenses. Business updates and financial results detailed Financial Results Moderna Inc. Business Updates Operating Expenses Q3 Revenue
BRIEF published on 11/03/2025 at 13:05, 2 months 28 days ago Moderna lance un essai de phase 1/2 pour un traitement du myélome multiple Moderna Myélome Multiple Étude De Phase 1/2 ARNm-2808 Engager Les Lymphocytes T
BRIEF published on 11/03/2025 at 13:05, 2 months 28 days ago Moderna Initiates Phase 1/2 Trial for Multiple Myeloma Therapy Moderna Multiple Myeloma Phase 1/2 Study MRNA-2808 T-Cell Engager
PRESS RELEASE published on 11/03/2025 at 13:00, 2 months 28 days ago Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma Moderna doses first patient with mRNA-2808 in Phase 1/2 study for multiple myeloma. Targets validated myeloma-associated antigens to combat resistance mechanisms Moderna Multiple Myeloma Phase 1/2 Study MRNA-2808 T-Cell Engager
BRIEF published on 10/23/2025 at 20:47, 3 months 8 days ago Moderna Recognized as Top Employer for Eleventh Year in a Row Innovation Moderna MRNA Top Employer MNEXSPIKE
BRIEF published on 10/23/2025 at 20:47, 3 months 8 days ago Moderna reconnue comme l'un des meilleurs employeurs pour la onzième année consécutive Innovation Moderne ARNm Meilleur Employeur MNEXSPIKE
PRESS RELEASE published on 10/23/2025 at 20:42, 3 months 8 days ago Moderna Named a Top Employer by Science for Eleventh Consecutive Year Moderna, Inc. named a top employer in biopharmaceutical industry by Science for 2025. Recognized for innovation, commitment, and culture Moderna Inc. Biopharmaceutical Industry MRNA Technology Top Employer Science Survey
BRIEF published on 10/23/2025 at 13:05, 3 months 9 days ago Moderna organise un événement pour les investisseurs le 20 novembre 2025 Webcast Moderne Événement Pour Les Investisseurs Technologie De L'ARNm Journée Des Analystes
BRIEF published on 10/23/2025 at 13:05, 3 months 9 days ago Moderna to Host Investor Event on November 20, 2025 Webcast MRNA Technology Moderna Investor Event Analyst Day
Published on 01/31/2026 at 03:15, 1 day 12 hours ago Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 01:40, 1 day 13 hours ago Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/30/2026 at 23:00, 1 day 16 hours ago Avidian Gold Corp. Announces Director Resignation
Published on 01/31/2026 at 15:54, 23 hours 40 minutes ago EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 1 day 3 hours ago JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 1 day 12 hours ago CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 1 day 17 hours ago Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 1 day 19 hours ago Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 18:40, 1 day 20 hours ago ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 17:45, 1 day 21 hours ago Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 1 day 21 hours ago Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 2 days 7 hours ago Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés
